Answers are grounded in this paper and cite their sources.
Observational analysis reveals favorable outcomes of ozanimod treatment in adults with multiple sclerosis, indicating effective management.
Ozanimod was well-tolerated with good treatment persistence, a favorable safety profile, and reductions in clinical and radiographic disease.
No takes yet. Share an insight, caveat, or question.
Cooperrider et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: